Scientists have developed a blood test that may reveal changes in the brain caused by Alzheimer’s disease. The technique, tested so far only in mice, predicts the amount of amyloid plaque (formed from clumps of proteins that kill surrounding cells) in an animal’s brain. The research, detailed in a report in the current issue of the journal Science, holds promise for the development of predictive methods to diagnose the disease years ahead of the onset of clinical symptoms.
David Holtzman of the Washington University School of Medicine and colleagues worked with mice that had been genetically engineered to develop an Alzheimer’s-like disease. They measured the amount of amyloid-b (Ab) protein in the animals’ blood and found that it did not correlate to the extent of plaque formation in the brain, which is also the case for humans. But when they treated 49 animals with an artificial antibody known as m266, they found that their levels of Ab increased dramatically within as little as five minutes. Moreover, the increased blood levels correlated with the amount of amyloid in two regions of the brain affected by Alzheimer’s, the hippocampus and the cingulate cortex. According to study co-author Ronald B. DeMattos of Washington University School of Medicine, "a simple injection of m266 altered the metabolism of Ab and unmasked important correlations with brain pathology."
Whether the results will apply to humans suffering from Alzheimer’s disease remains unclear. Even if the test does work, it can only diagnose patients who have already started to accumulate amyloid. But as Holtzman notes, "such a test also could distinguish individuals suffering from dementia caused by Alzheimer’s from those with other types of dementia, and may help us evaluate an individual’s response to particular medical therapies."
Sarah Graham | Scientific American
Biofilm discovery suggests new way to prevent dangerous infections
23.05.2017 | University of Texas at Austin
Another reason to exercise: Burning bone fat -- a key to better bone health
19.05.2017 | University of North Carolina Health Care
The world's highest gain high power laser amplifier - by many orders of magnitude - has been developed in research led at the University of Strathclyde.
The researchers demonstrated the feasibility of using plasma to amplify short laser pulses of picojoule-level energy up to 100 millijoules, which is a 'gain'...
Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.
Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....
Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.
The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....
An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.
We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...
Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.
Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...
24.05.2017 | Event News
23.05.2017 | Event News
22.05.2017 | Event News
29.05.2017 | Earth Sciences
29.05.2017 | Life Sciences
29.05.2017 | Physics and Astronomy